A VLP vaccine platform comprising the core protein of hepatitis B virus with N-terminal antigen capture (2024)
Attributed to:
Manufacturing research hub for a sustainable future: Vaccines for pandemic preparedness
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1101/2024.06.07.597873
Publication URI: http://dx.doi.org/10.1101/2024.06.07.597873
Type: Preprint